top of page
News
Search
Renovion Announces Positive Top-Line Results from Phase 2 CLIMB Study of ARINA-1 (RVN-301) in Patients with Non-Cystic Fibrosis Bronchiectasis
Elevated QOL in NCFBE patients with ARINA-1 treatment. Robust data show significant symptom improvement surpassing clinical thresholds.
Renovion
Apr 30, 20245 min read
Renovion Completes Enrollment of Adult Patients in Phase 2 CLIMB Study in Bronchiectasis
Renovion Inc., a company focused on restoring lung health in patients with bronchiectasis, announces patient enrollment for Phase 2 trial.
Renovion
Jan 11, 20242 min read
Interview with the Lung Transplant Foundation: Participating in a Lung Transplant Clinical Trial
Carolyn Durham, CSO at Renovion and Amy S., ED at the LTx Foundation discuss real-world experience of being in a clinical trial in LTx.
Renovion
Oct 10, 20231 min read
First Patient Enrolled in Phase 3 Clinical Trial Evaluating ARINA-1 in Lung Transplant
Source | Business Wire April 18, 2023 08:52 AM Eastern Daylight Time CHAPEL HILL, N.C - Renovion, Inc. today announced that the first...
Renovion
Apr 18, 20232 min read
Double breath of fresh air for Triangle startup: $15M in new cash, fast track status for treatment
Startup Renovion, its marketing slogan “Restoring Lung Health One Breath at a Time,” has gotten two doses of fresh air for its treatment eff
Renovion
Apr 3, 20231 min read
bottom of page